Company / Accounts Receivable
QuidelOrtho Accounts Receivable History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$417.0M
FY2025
5-year range
$282.4M / $417.0M
FY2023-FY2025
Trend
+47.7%
vs FY2024
Sector context
#52 of 143
Health Care
What the data says
At $417M, QuidelOrtho's accounts receivable ranks #52 of 143 in the Health Care sector. Improved from $303M to $417M over the past 2 years.
Based on SEC 10-K filings.
$417M in FY2025.
Improved from $303M to $417M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#52 of 143 in Health CareTop 36% of 143This company $417.0M Sector average $1.3B
▼
-68.6% below sector average
Key checks
Key Insights
- In FY2025, accounts receivable increased 47.7% year-over-year.
- Ranks #52 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $417.0M | +47.7% |
| FY2024 | $282.4M | -6.9% |
| FY2023 | $303.3M | - |
| FY2022 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026